Related Experiment Video
Updated: Nov 18, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia
Manasawee Srisuttayasathien1, Nutthada Areepium2, Ruangsak Lertkhachonsuk1
1Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Chulalongkorn University & King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Abstract:
Aim: The aim of this study was to explore the effects of ABCB1 and SLCO1B1 gene polymorphisms and the methotrexate (MTX) treatment response in patients with low-risk gestational trophoblastic neoplasia (GTN). Materials & methods: Low-risk GTN patients who received MTX as a first-line single agent were enrolled. DNA was extracted from peripheral blood samples from 18 patients and assessed for ABCB1 C3435T and SLCO1B1 T521C. Results:ABCB1 C3435T and SLCO1B1 T521C polymorphisms were not associated with the MTX response or toxicity in Thai patients Conclusion: The selected ABCB1 and SLCO1B1 polymorphism do not predict the risk of MTX resistance in low-risk GTN.
Related Concept Videos
Treatment Resistant Cancers
ABC Transporters: Exporter

